Overview

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To test the efficacy of CP-751,871 combined with exemestane in the treatment of postmenopausal patients with hormone positive advanced breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Antibodies, Monoclonal
Exemestane
Fulvestrant
Hormones